Landlocked developing countries (LLDCs) vs Portugal: Proportion of the target population who received a 3rd dose of
Landlocked developing countries (LLDCs)
76.0%
in 2024
Portugal
98.0%
in 2024
Landlocked developing countries (LLDCs) rank
17th
Portugal rank
7th
Proportion of the target population who received a 3rd dose of over time
- Landlocked developing countries (LLDCs)
- Portugal
How they compare
Portugal currently reports 98.0% against 76.0% in Landlocked developing countries (LLDCs), a difference of 22.0%.
That makes Portugal's figure about 1.3 times Landlocked developing countries (LLDCs)'s.
Across all 9 years both countries report, Portugal has been ahead every year.
Landlocked developing countries (LLDCs) ranks 17th and Portugal ranks 7th of 37 groups.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 69.0% | 91.2% | 22.2% | Portugal |
| 2020s | 72.2% | 98.0% | 25.8% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Landlocked developing countries (LLDCs) or Portugal?
- Portugal, at 98.0% against 76.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Landlocked developing countries (LLDCs) and Portugal?
- 22.0%, with Portugal ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Portugal?
- 9 years are reported by both, from 2016 to 2024.
- How do Landlocked developing countries (LLDCs) and Portugal rank globally for proportion of the target population who received a 3rd dose of?
- Landlocked developing countries (LLDCs) ranks 17th and Portugal ranks 7th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.